The World Market for Personalized Medicine Tests for Cancer
This report, Personalized Medicine Tests for Cancer, provides an authoritative look at the market for companion and personalized medicine testing for cancer. The report includes a market size and forecast for personalized medicine testing by geography (US, EU, ROW). Company profiles are included and products are identified by status (on the market, in development)
- Executive Summary
- The Scourge of Cancer
- Definitions of Companion Diagnostics and Cancer Diagnostics
- Types of Tests Included
- Marketing Personalized Medicine-Based Cancer Tests
- Market
- Point of View
- Introduction
- Cancer Treatments
- Table Biomarkers Used in Cancer Tests
- Cancer Risk Assessment
- Cancer Screening
- Cancer Monitoring
- Prognosis Assessment
- Technologies Used
- Immunoassays:
- Immunohistochemistry (IHC):
- Flow Cytometry:
- In Situ Hybridization:
- Nucleic Acid Amplification Technologies:
- Analysis of Gene Expression Patterns (Gene Signatures):
- Microarrays:
- Sequencing Technologies:
- Mass Spectrometry:
- Liquid Biopsies:
- Information Technology:
- Test Targets
- HER2 Overexspression
- EGFR
- KRAS Mutations
- BRAF Mutations
- UGT1A1 Genetic Variants
- 5-Flurouracil Therapy
- PIK3CA Mutations
- KIF6 Mutations
- ALK Mutations
- Market Analysis
- Products on the Market
- Table Personalized Medicine Testing Products for Cancer on the Market and In Development
- Market Analysis
- Table The Market for Personalized Medicine Testing for Cancer by Geographic Region , 2016 and 2021 $ Millions
- Drivers
- Diagnostic Companies and Pharmaceutical Companies
- Growth by Geography
- Company Profiles.
- 20/20 GeneSystems, Inc.
- Abbott Laboratories
- ACT Genomics Co., Ltd.
- Adaptive Biotechnologies Corporation
- Admera Health (A GENEWIZ Company)
- Agena Bioscience Inc.
- Agendia NV
- Amoy Diagnostics Co., Ltd.
- ARKRAY, Inc.
- Biocartis
- Company Overview
- Products
- Pharmaceutical Company Agreements
- bioMérieux SA
- Cepheid (Danaher)
- Genomic Health, Inc.
- Genoptix (A Novartis Company)
- Luminex Corporation
- Myriad Genetics, Inc.
- Qiagen N.V.
- QuanDx Inc.
- Quest Diagnostics
- Qvella Corporation
- RiboMed Biotechnologies, Inc.
- Roche
- Siemens Healthcare
- Symbiodx
- Theranostics Health Inc. (Acquired by Avant Diagnostics, Inc.)
- Thermo Fisher Scientific, Inc.